BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burdach S, Kolb HJ. The vigor of defense against non-self: potential superiority of allorestricted T cells in immunotherapy of cancer? Front Oncol 2013;3:100. [PMID: 23653891 DOI: 10.3389/fonc.2013.00100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Pando A, Fast L, Dubielecka PM, Chorzalska A, Wen S, Reagan J. Murine Leukemia-Derived Extracellular Vesicles Elicit Antitumor Immune Response. J Blood Med 2021;12:277-85. [PMID: 34040472 DOI: 10.2147/JBM.S308861] [Reference Citation Analysis]
2 Kirschner A, Thiede M, Grünewald TG, Alba Rubio R, Richter GH, Kirchner T, Busch DH, Burdach S, Thiel U. Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma in vitro and in vivo. Oncoimmunology 2017;6:e1273301. [PMID: 28344885 DOI: 10.1080/2162402X.2016.1273301] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
3 Corcos D. Food-Nonfood Discrimination in Ancestral Vertebrates: Gamete Cannibalism and the Origin of the Adaptive Immune System. Scand J Immunol 2015;82:409-17. [PMID: 26286030 DOI: 10.1111/sji.12348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Schirmer D, Grünewald TG, Klar R, Schmidt O, Wohlleber D, Rubío RA, Uckert W, Thiel U, Bohne F, Busch DH, Krackhardt AM, Burdach S, Richter GH. Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity. Oncoimmunology 2016;5:e1175795. [PMID: 27471654 DOI: 10.1080/2162402X.2016.1175795] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
5 Burdach SEG, Westhoff MA, Steinhauser MF, Debatin KM. Precision medicine in pediatric oncology. Mol Cell Pediatr 2018;5:6. [PMID: 30171420 DOI: 10.1186/s40348-018-0084-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
6 Blaeschke F, Thiel U, Kirschner A, Thiede M, Rubio RA, Schirmer D, Kirchner T, Richter GHS, Mall S, Klar R, Riddell S, Busch DH, Krackhardt A, Grunewald TG, Burdach S. Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivo. Oncotarget 2016;7:43267-80. [PMID: 27281613 DOI: 10.18632/oncotarget.9218] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
7 Thiel U, Schober SJ, Einspieler I, Kirschner A, Thiede M, Schirmer D, Gall K, Blaeschke F, Schmidt O, Jabar S, Ranft A, Alba Rubío R, Dirksen U, Grunewald TGP, Sorensen PH, Richter GHS, von Lüttichau IT, Busch DH, Burdach SEG. Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells. Oncoimmunology 2017;6:e1312239. [PMID: 28638739 DOI: 10.1080/2162402X.2017.1312239] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]